Heterozygous Familial Hypercholesterolemia (HeFH)Symptoms, Doctors, Treatments, Advances & More
Learn About Heterozygous Familial Hypercholesterolemia (HeFH)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Vascular And Endovascular Surgery At The Mount Sinai Hospital
Robert Rosenson is a Cardiologist in New York, New York. Dr. Rosenson is rated as an Elite provider by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). His top areas of expertise are Homozygous Familial Hypercholesterolemia (HoFH), High Cholesterol, Defective Apolipoprotein B-100, Atherosclerosis, and Percutaneous Coronary Intervention (PCI).
OHSU Hospital
Paul Duell is an Endocrinologist in Portland, Oregon. Dr. Duell is rated as an Elite provider by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). His top areas of expertise are Familial Hypercholesterolemia, Defective Apolipoprotein B-100, Homozygous Familial Hypercholesterolemia (HoFH), and Heterozygous Familial Hypercholesterolemia (HeFH).
Mika Hori practices in Nagoya, Japan. Hori is rated as an Elite expert by MediFind in the treatment of Heterozygous Familial Hypercholesterolemia (HeFH). Their top areas of expertise are Heterozygous Familial Hypercholesterolemia (HeFH), Familial Hypercholesterolemia, High Cholesterol, Defective Apolipoprotein B-100, and Pancreaticoduodenectomy.
Summary: VT-10201 is an Open-label, Phase 1b, Single-ascending Dose Study That Will Evaluate the Safety of VERVE-102 Administered to Patients With Heterozygous Familial Hypercholesterolemia (HeFH) or Premature Coronary Artery Disease (CAD) Who Require Additional Lowering of LDL-C. VERVE-102 Uses Base-editing Technology Designed to Disrupt the Expression of the PCSK9 Gene in the Liver and Lower Circulating ...
Summary: This study is designed to learn if enlicitide decanoate is safe and effective to treat children and adolescents with heterozygous familial hypercholesterolemia (HeFH) and high amounts of low-density lipoprotein cholesterol (LDL-C) in the blood. The goals of this study are to learn about the safety of enlicitide and if children tolerate it, what happens to enlicitide in a child's body over time, an...